Literature DB >> 22470108

Involvement of reactive oxygen species and JNK in increased expression of MCP-1 and infiltration of inflammatory cells in pressure-overloaded rat hearts.

Fujun Shang1, Jiepin Wang, Xiongtao Liu, Jun Li, Qiangsun Zheng, Yusheng Xue, Lianyou Zhao.   

Abstract

Increasing evidence has shown that inflammation is involved in pressure overload-induced cardiac remodeling. Monocyte chemoattractant protein-1 (MCP-1) plays a pivotal role in the inflammatory process. However, the mechanisms underlying the upregulation of MCP-1 expression remain poorly understood. In the present study, we examined the hypothesis that an increased production of reactive oxygen species (ROS) mediates the upregulation of MCP-1. In a pressure-overloaded rat heart model with abdominal aortic coarctation (AC), superoxide dismutase-inhibitable cytochrome C reduction assay showed that ROS generation in the myocardium increased significantly at 1 week by 61% (n=8, P<0.01), peaked at 2 weeks and maintained these high levels for 4 weeks. The elevation of ROS was paralleled by the increased expression of MCP-1 and left ventricular remodeling (cardiac hypertrophy, perivascular and interstitial fibrosis). The oral administration of the antioxidant, N-acetylcysteine (NAC, 0.2 g/kg/day), for 2 or 4 weeks, significantly attenuated ROS production by 69 and 68%, respectively (n=8, P<0.01), as well as left ventricular remodeling. NAC treatment for 2 weeks also significantly reduced the MCP-1 mRNA and protein levels by 52 and 60%, respectively (n=4-8, both P<0.01), but had no effect on blood pressure. In the rats with AC at 2 weeks, when MCP-1 expression and inflammation changes were overt, immunoblotting with phospho-specific antibodies revealed that extracellular regulated kinase (ERK) and c-jun NH2-terminal kinase (JNK), but not p38 mitogen-activated protein kinase, were activated. NAC administration attenuated JNK activation, but had no effect on ERK. Our results suggest that increased ROS production may play an important role in the increased expression of MCP-1 in pressure overload-induced cardiac remodeling. JNK is likely involved in the signaling pathway.

Entities:  

Keywords:  reactive oxygen species; hypertension; pressure overload-induced cardiac remodeling; monocyte chemoattractant protein-1

Mesh:

Substances:

Year:  2012        PMID: 22470108     DOI: 10.3892/mmr.2012.852

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

1.  [Molecular mechanisms of exercise-induced cardiovascular adaptations. Influence of epigenetics, mechanotransduction and free radicals].

Authors:  W Bloch; F Suhr; P Zimmer
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

2.  CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway.

Authors:  Jia-Hong Wang; Feng Su; Shijun Wang; Xian-Cheng Lu; Shao-Heng Zhang; De Chen; Nan-Nan Chen; Jing-Quan Zhong
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.

Authors:  Waylan K Bessler; Grace Kim; Farlyn Z Hudson; Julie A Mund; Raghuveer Mali; Keshav Menon; Reuben Kapur; D Wade Clapp; David A Ingram; Brian K Stansfield
Journal:  Hum Mol Genet       Date:  2016-01-05       Impact factor: 6.150

4.  Differential phenotypes of tissue-infiltrating T cells during angiotensin II-induced hypertension in mice.

Authors:  Zihui Wei; Iresha Spizzo; Henry Diep; Grant R Drummond; Robert E Widdop; Antony Vinh
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

Review 5.  Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems.

Authors:  Veronica Dusi; Alice Ghidoni; Alice Ravera; Gaetano M De Ferrari; Laura Calvillo
Journal:  Mediators Inflamm       Date:  2016-05-03       Impact factor: 4.711

6.  Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19.

Authors:  Maria A Pedrosa; Rita Valenzuela; Pablo Garrido-Gil; Carmen M Labandeira; Gemma Navarro; Rafael Franco; Jose L Labandeira-Garcia; Ana I Rodriguez-Perez
Journal:  Clin Sci (Lond)       Date:  2021-02-12       Impact factor: 6.124

Review 7.  Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment.

Authors:  Jose L Labandeira-Garcia; Carmen M Labandeira; Rita Valenzuela; Maria A Pedrosa; Aloia Quijano; Ana I Rodriguez-Perez
Journal:  Biomedicines       Date:  2022-02-21

Review 8.  Modulation of Immune-Inflammatory Responses in Abdominal Aortic Aneurysm: Emerging Molecular Targets.

Authors:  Hanrong Li; Shuling Bai; Qiang Ao; Xiaohong Wang; Xiaohong Tian; Xiang Li; Hao Tong; Weijian Hou; Jun Fan
Journal:  J Immunol Res       Date:  2018-06-03       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.